Hardik Gandhi

492 total citations
34 papers, 378 citations indexed

About

Hardik Gandhi is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Surgery. According to data from OpenAlex, Hardik Gandhi has authored 34 papers receiving a total of 378 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 6 papers in Pathology and Forensic Medicine and 5 papers in Surgery. Recurrent topics in Hardik Gandhi's work include Cholesterol and Lipid Metabolism (3 papers), Quinazolinone synthesis and applications (3 papers) and Cardiac Ischemia and Reperfusion (3 papers). Hardik Gandhi is often cited by papers focused on Cholesterol and Lipid Metabolism (3 papers), Quinazolinone synthesis and applications (3 papers) and Cardiac Ischemia and Reperfusion (3 papers). Hardik Gandhi collaborates with scholars based in India, United States and Slovakia. Hardik Gandhi's co-authors include R Balaraman, Aman Upaganlawar, Mange Ram Yadav, Rajani Giridhar, S. Desai, Ranjitsinh V. Devkar, Dipak Patel, A. V. Ramachandran, Prashant Naik and N. J. Patni and has published in prestigious journals such as SHILAP Revista de lepidopterología, European Journal of Pharmacology and RSC Advances.

In The Last Decade

Hardik Gandhi

32 papers receiving 342 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hardik Gandhi India 10 85 83 72 72 46 34 378
Kesavarao Kumar Ebenezar India 10 113 1.3× 138 1.7× 85 1.2× 51 0.7× 40 0.9× 26 373
Yi Qu China 8 162 1.9× 52 0.6× 79 1.1× 63 0.9× 25 0.5× 13 402
Hongchen Lin China 6 147 1.7× 50 0.6× 78 1.1× 58 0.8× 22 0.5× 7 359
Arash Khorrami Iran 15 229 2.7× 81 1.0× 78 1.1× 88 1.2× 57 1.2× 32 617
Carla Maria Lins de Vasconcelos Brazil 15 153 1.8× 56 0.7× 63 0.9× 132 1.8× 55 1.2× 51 507
Abeer Elkhoely Egypt 12 117 1.4× 49 0.6× 73 1.0× 46 0.6× 45 1.0× 22 319
Eun Jeong Choi South Korea 7 120 1.4× 40 0.5× 31 0.4× 35 0.5× 40 0.9× 16 374
Ho Won Seo South Korea 17 220 2.6× 64 0.8× 84 1.2× 82 1.1× 39 0.8× 29 547
Pramod C. Gadad India 10 117 1.4× 67 0.8× 55 0.8× 54 0.8× 43 0.9× 22 476
Diego Santos Souza Brazil 13 148 1.7× 61 0.7× 48 0.7× 132 1.8× 51 1.1× 43 408

Countries citing papers authored by Hardik Gandhi

Since Specialization
Citations

This map shows the geographic impact of Hardik Gandhi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hardik Gandhi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hardik Gandhi more than expected).

Fields of papers citing papers by Hardik Gandhi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hardik Gandhi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hardik Gandhi. The network helps show where Hardik Gandhi may publish in the future.

Co-authorship network of co-authors of Hardik Gandhi

This figure shows the co-authorship network connecting the top 25 collaborators of Hardik Gandhi. A scholar is included among the top collaborators of Hardik Gandhi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hardik Gandhi. Hardik Gandhi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Nasiri, Mohammad Javad, Maryam Amiri, Giovanni Sotgiu, et al.. (2025). 15-year trends in efficacy and effectiveness of treatment outcomes in drug-resistant pulmonary TB. PubMed. 2(4). 187–198.
2.
Win, Khin Maung, et al.. (2025). Effects of a novel weight-loss combination product containing orlistat and resveratrol on obesity: A multicenter randomized controlled study (EC-FIT). SHILAP Revista de lepidopterología. 17. 100218–100218. 1 indexed citations
3.
Gandhi, Hardik, et al.. (2023). Hypertensive Emergency As Initial Presentation of Systemic Sclerosis Sine Scleroderma. Cureus. 15(4). e37817–e37817. 1 indexed citations
4.
Gandhi, Hardik, et al.. (2022). Histopathological analysis of hysterectomy specimens. National Journal of Physiology Pharmacy and Pharmacology. 1–1. 1 indexed citations
5.
Zhang, Pingchuan, et al.. (2022). Lithium-induced nephropathy; One medication with multiple side effects: a case report. BMC Nephrology. 23(1). 309–309. 6 indexed citations
6.
Gandhi, Hardik, et al.. (2017). Vicinal diaryl azole-based urea derivatives as potential cholesterol lowering agents acting through inhibition of SOAT enzymes. European Journal of Medicinal Chemistry. 130. 107–123. 9 indexed citations
7.
Gandhi, Hardik, et al.. (2016). Protective effects of MCR-1329, a dual α1 and angII receptor antagonist, in mineralocorticoid-induced hypertension. Pharmacological Reports. 68(5). 952–959. 1 indexed citations
8.
Gandhi, Hardik, et al.. (2015). A Research on Enhancing Public Key Cryptography by the Use of MRGA with RSA and N-Prime RSA. 1(12). 91–98. 1 indexed citations
9.
Variya, Bhavesh C., et al.. (2015). Comparative evaluation of HMG CoA reductase inhibitors in experimentally-induced myocardial necrosis: Biochemical, morphological and histological studies. European Journal of Pharmacology. 764. 283–291. 9 indexed citations
10.
Giridhar, Rajani, et al.. (2015). Design, green synthesis and pharmacological evaluation of novel 5,6-diaryl-1,2,4-triazines bearing 3-morpholinoethylamine moiety as potential antithrombotic agents. Journal of Enzyme Inhibition and Medicinal Chemistry. 31(5). 704–713. 8 indexed citations
11.
Naik, Prashant, et al.. (2015). Management of Hypertension-Journey from Single Drug Therapy to Multitargeted Ligand Therapy: A Clinical Overview. Current Clinical Pharmacology. 10(4). 321–346. 8 indexed citations
12.
Yadav, Mange Ram, et al.. (2013). Design and synthesis of 6,7-dimethoxyquinazoline analogs as multi-targeted ligands for α1- and AII-receptors antagonism. Bioorganic & Medicinal Chemistry Letters. 23(13). 3959–3966. 9 indexed citations
13.
Gandhi, Hardik, et al.. (2013). Carboplatin-induced Fanconi-like syndrome in rats: Amelioration by pentoxifylline. Environmental Toxicology and Pharmacology. 37(1). 185–194. 4 indexed citations
14.
Patel, Dipak, S. Desai, Hardik Gandhi, Ranjitsinh V. Devkar, & A. V. Ramachandran. (2012). Cardio protective effect of Coriandrum sativum L. on isoproterenol induced myocardial necrosis in rats. Food and Chemical Toxicology. 50(9). 3120–3125. 56 indexed citations
15.
Rathi, Suresh Kumar, et al.. (2011). Modeling for appropriate awareness of H1N1 influenza among urban population of Vadodara, India. SHILAP Revista de lepidopterología. 1 indexed citations
16.
Yadav, Mange Ram, Hardik Gandhi, Prashant Naik, & Rajani Giridhar. (2011). Revelation on the potency of α1-blockers – parallel blockade of angiotensin II receptor: A new finding. Pharmaceutical Biology. 50(4). 439–442. 9 indexed citations
17.
Francis, Mark, Suresh Kumar Rathi, & Hardik Gandhi. (2011). Knowledge and Awareness about H1N1 Flu in Urban Adult Population of Vadodara, India. SHILAP Revista de lepidopterología. 2 indexed citations
18.
Gandhi, Hardik, Vishal Patel, & Aman Upaganlawar. (2011). Ipilimumab: Melanoma and beyond. Journal of Pharmacy And Bioallied Sciences. 3(4). 546–546. 4 indexed citations
19.
Balaraman, R & Hardik Gandhi. (2010). Asenapine, a new sublingual atypical antipsychotic. Journal of Pharmacology and Pharmacotherapeutics. 1(1). 60–61. 21 indexed citations
20.
Gandhi, Hardik, Aman Upaganlawar, & R Balaraman. (2010). Adipocytokines: The pied pipers. Journal of Pharmacology and Pharmacotherapeutics. 1(1). 9–17. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026